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rette smoked. We hypothesized that in addition to
smoking frequency, other behavioral measures of nic-
otine dependence, such as the time to first cigarette
after waking, are associated with cotinine levels. To
test this hypothesis, we measured plasma and urinary
cotinine in a community-based study of 252 black and
white daily cigarette smokers. Among one pack per
day smokers, plasma cotinine levels varied from 16
to 1,180 ng/mL, a 74-fold difference. Two nicotine de-
pendence phenotypes were discerned by time after
waking. Subjects in the “low” dependent phenotype
smoked >30 minutes after waking and nearly all
smoked ≤20 cigarettes per day. Cotinine levels in-
creased linearly with cigarette consumption in this
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Cancer Epidemiol Biomarkers Prevsmoked ≤30 minutes after waking but had a wide
range in the frequency of daily cigarettes (6-70). Com-
pared with the low dependent phenotype, there were
relatively small differences in cotinine by cigarette
frequency with evidence of a plateau effect in heavy
smokers (∼30). After adjusting for cigarette frequency,
the levels of cotinine by time to first cigarette were as
follows: ≤5 minutes, 437 [95% confidence limits (CL),
380-494]; 6 to 30 minutes, 352 (95% CL, 291-413), 31 to
60 minutes, 229 (95% CL, 140-317), and >60 minutes,
215 (95% CL, 110-321). Similar findings were observed
for urinary cotinine. These findings suggest that the
time to first cigarette is a strong predictor of nicotine
uptake and should be considered in the design of
smoking interventions. (Cancer Epidemiol Biomarkers
Prev 2009;18(12):3415–20)Introduction
Nicotine uptake, as measured by the major nicotine me-
tabolite cotinine, increases with the numbers of cigarettes
smoked per day in a dose-dependent relationship (1-9).
In most studies, cotinine levels tend to level off or even
slightly decrease at about one pack per day. In the Nation-
al Health and Nutrition Examination Surveys, the ratio of
cotinine per cigarette smoked tended to decline linearly
and leveled off at 20 cigarettes per day (10). This plateau
effect as well as differences in demographics, cigarette
nicotine yields, and nicotine metabolism partly explain
why the frequency of daily smoking is only moderately
correlated with cotinine levels (r = 0.36-0.82; refs. 1, 2, 4,
10). Because the risk of lung cancer risk associated with
cigarette smoking also plateaus with high smoking con-
sumption (11-14), cotinine levels might be a marker of risk
and not just exposure.
In pharmacodynamic studies, nicotine intake stimu-
lates neural systems at low doses and suppresses at high
doses (15). Many smokers develop nicotine tolerance, and
smoking cessation causes withdrawal symptoms, includ-
ing cravings, depression, and increased appetite. Smokers
consume nicotine to both experience its stimulative effects
and avoid withdrawal symptoms. In particular, the crav-
ings of the smokers after overnight abstinence and theability to tolerate cigarettes immediately after waking
are strong indicators of nicotine dependence (16-18).
The time to first cigarette after waking up has become in-
creasingly recognized as one of the best measures of nic-
otine dependence because it is also associated with many
other aspects of dependence, including smoking cessation
(18, 19), smoking relapse (20), and tolerance (21). Time to
first cigarette is one of the items that comprise the six-item
Fagerström Test for Nicotine Dependence (FTND), and
much of the predictive value of the FTND has been attrib-
uted to the time to first cigarette (22-24).
The time to first cigarette was originally conceptualized
as a categorical variable (≤5 minutes, 6-30 minutes, 31-60
minutes, and >60 minutes) based on its relationship with
“heavy smoking.” A quicker time to first cigarette was as-
sociated with higher expired carbon monoxide and coti-
nine levels (24). The current analysis was therefore
conducted to determine whether this simple behavioral
measure of dependence affects the physiologic uptake of
nicotine (e.g., cotinine) independently of cigarettes per
day and whether it affects the shape of the relationship
between smoking frequency and cotinine.Materials and Methods
We designed and conducted a participatory-based study
of adult cigarette smokers ages 18 to 55 y in lower and
central Westchester County, New York, to investigate ra-
cial differences in smoke exposure and metabolism. The
details were described previously (1). The study included
subjects who smoked at least five cigarettes per day for 1
or more years. Subjects were recruited by community ci‐
vic and church leaders, word-of mouth recommendations2009;18(12). December 2009
3416 Time to First Cigarette and Cotininefrom participants, as well as newspaper advertisements
and other media. All subjects signed a consent form ap-
proved by the Institutional Review Board of the American
Health Foundation/Institute for Cancer Prevention.
Trained interviewers administered a structured question-
naire that contained detailed items on cigarette smoking
history and, for a subset of subjects, the six-item FTND.
One of the FTND items is the question “How soon after
waking up do you smoke your first cigarette?” Nicotine
uptake was determined by measuring plasma cotinine
(ng/mL) and urinary cotinine (μg/mg creatinine). There
were 242 subjects who had plasma cotinine determina-
tions and 252 had urinary cotinine determinations.
Statistical Analysis. All analyses were done using Sta-
tistical Analysis System statistical software (version 9;
SAS). Univariate analysis of untransformed statistics is
presented, including means and SDs. The Pearson corre-
lation coefficient was used to assess the association be-
tween time to first cigarette, based on a four-point scale,
and smoking measures, such as cigarette frequency and
cotinine. All statistical tests were two-sided. Graphs of
the relationship between cigarettes per day and cotinine
levels were produced using Microsoft Excel.
Linear regression methods were used to model coti-
nine levels against cigarettes per day. A departure from
linearity was tested using a squared term for cigarettes
per day. Cotinine levels were not further regressed
against the FTND because of its high collinearity with
cigarettes per day. Multivariate modeling was conducted
using the natural logarithm of cotinine. In addition to
daily cigarette consumption, the following covariates
were included in each model: age (continuous), years
of education (continuous), race (categorical), sex (cate-
gorical), and time to first cigarette (>30 min versus
≤30 min). For each covariate, we tested for effect modi-
fication by including interaction terms with cigarettes
per day. Differences in mean cotinine levels were also
compared between the four categories of time to first
cigarette. Significance level was set at 0.05.Results
There was substantial variability in the levels of cotinine
per cigarette smoked. The levels of plasma cotinine in
subjects who smoked 20 cigarettes per day varied from
16 to 1,180 ng/mL, a 74-fold difference. Two nicotine de-
pendence phenotypes could be discerned from these
data. A “low” dependent phenotype included subjects
who smoked >30 minutes after waking up. Almost all
of these subjects smoked ≤20 cigarettes per day and
had relatively low mean levels of plasma cotinine (204 ±
202 ng/mL) and urinary cotinine (2,690 ± 3,100 μg/mg
creatinine). The levels of cotinine increased linearly with
no evidence of a plateau effect, as there were few heavyCancer Epidemiol Biomarkers Prevsmokers (n = 4). The “high” dependent phenotype in-
cluded subjects who smoked ≤30 minutes after waking.
In contrast to the low dependent phenotype, there was a
wide range of cigarette consumption in this group. The
mean level of plasma cotinine (397 ± 294 ng/mL) and
urinary cotinine (4,490 ± 3,540 μg/mg creatinine) was al-
most twice as high as that for smokers in the low depen-
dent group. Highly dependent subjects who smoked 10
cigarettes per day had higher cotinine levels than low
dependent subjects who smoked 20 cigarettes daily
(plasma: 326 ± 291 versus 268 ± 270 ng/mL; urinary:
3,050 ± 2,230 versus 2,970 ± 2,320 μg/mg creatinine).
The levels of biomarkers in the highly dependent group
did not increase with cigarette frequency as much as that
in the less dependent group, and there was a clear pla-
teau effect at ∼30 cigarettes.
Table 1 shows that the time to first cigarette was sig-
nificantly correlated with cigarettes per day (r = 0.34)
and both plasma (r = 0.33) and urinary cotinine (r =
0.27). Figure 1A shows the relationship between cigarettes
per day and log-transformed plasma and urinary cotinine
concentrations. The slope for both measures levels off at
about 25 to 30 cigarettes per day. In a linear regression
model of log-transformed plasma cotinine that included
the covariates and their interaction terms, age was a sig-
nificant predictor (P < 0.01). The test for the slope of cigar-
ettes per day by time after waking categories (≤30
minutes versus >30 minutes) was statistically significant
(P < 0.05). We subsequently modeled cotinine separately
by these two categories. Cigarette frequency was not
a significant predictor in subjects who smoked within
30 minutes (e.g., the high dependent group) but was sig-
nificant in the low dependent group. Figure 1B shows the
time to first cigarette-specific relationship between plas-
ma cotinine and cigarette frequency.
In the model of log-transformed urinary cotinine, the
effect of age did not reach statistical significance (P =
0.08). Interaction terms for cigarette frequency * time to
first cigarette and cigarette frequency * sex were both
statistically significant (P < 0.01). The relationships are
shown in Fig. 1C and D for men and women, respective-
ly. As with plasma cotinine, the slopes were flatter for
highly dependent smokers and showed evidence of a
plateau effect. [In women who smoked ≥30 minutes af-
ter waking, there was only one subject who smoked >20
cigarettes (i.e., 60 cigarettes per day).]
The mean levels of plasma cotinine were compared
between the four categories of the time to first cigarette
variable. After adjusting for cigarettes per day and race,
there was a clear trend in decreasing cotinine levels with
a longer time to first cigarette. The differences in mean
levels between each group were significant, except for
the 31- to 60-minute group versus the >60-minute group
(Table 2). Similar findings were observed for urinary
cotinine (Table 3).Table 1. Correlation matrix of cigarettes smoked per day and cotinine in a community-based study, New YorkMeasure Time to first cigarette2009;1Plasma cotinine (ng/mL)8(12). December 2009Urinary cotinineCigarettes per day 0.34* 0.14* 0.28†
Time to first cigarette — 0.33* 0.27*
Plasma cotinine (ng/mL) — 0.54**P < 0.01.
†P < 0.05.
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The higher cotinine levels associated with a shorter time to
cigarette smoking after waking might be due to more in-
tense smoking in response to overnight abstinence. More
highly dependent smokers, as defined by the Fagerström
Tolerance Questionnaire (an earlier version of the FTND),
have increased compensatory smoking behaviors such as
puff number and puff duration than less dependent smo-
kers when switching to a low nicotine cigarette (25). There
are little data on the time to first cigarette and smoking in-
tensity. One recent study in adult smokers in the United
Kingdom measured puffing behaviors in relation to the
time of the day that cigarettes were smoked (26). Cigar-
ettes that were smoked within 5 minutes after waking
were associated with a significantly lower mean total
smoke volume than cigarettes smoked afterwards. These
data would seem to indirectly contradict our hypothesis,
although cotinine measurements were not reported in
the United Kingdom study. Our studies would need addi-
tional data on puffing profiles to make more definitive
conclusions on whether the association between time to
first cigarette and cotinine could be attributed to more in-
tense puffing behaviors and whether symptoms of nico-
tine cravings are greater after waking.Cancer Epidemiol Biomarkers PrevIn our study, highly dependent subjects who smoked
10 cigarettes per day had higher cotinine levels than less
dependent subjects who smoked 20 cigarettes per day.
The lack of a significant linear relationship between ciga-
rette frequency and cotinine in the highly dependent
group indicates important physiologic or metabolic fac-
tors such as the saturation of nicotine uptake and nicotine
metabolism may be occurring and/or reduction in stress
that affects inhalation. In smoking reduction trials, there
was no linear relationship between cigarettes per day
and baseline urinary cotinine in highly dependent sub-
jects (e.g., high FTND, time to first cigarette ≤30 minutes,
those who had difficulty giving up the first cigarette, and
subjects who smoked when ill).
The two suggested phenotypes in these data are not en-
tirely distinct nor would they be expected to be because
time to first cigarette and daily cigarette frequency are just
two behavioral measures of nicotine dependence, which
is characterized by a physiologic desire and craving for
nicotine, the perceived good feelings it generates, and un-
pleasant withdrawal symptoms. There are several behav-
ioral/symptom scales of nicotine dependence in use (26),
and their lack of a high concordance highlights the com-
plexity in defining nicotine dependence. We did not mea-
sure the many physiologic and psychological attributes ofFigure 1. A. Relation-
ship between cigarettes per
day and log-transformed
plasma and urinary cotinine
concentrations.B.Relation-
ship between cigarettes per
day and log-transformed
plasma cotinine by time to
first cigarette. C. Relation-
ship between cigarettes per
day and log-transformed
urinary cotinine/creatinine
in men by time to first cig-
arette. D. Relationship be-
tween cigarettes per day
and log-transformed uri-
nary cotinine/creatinine
in women by time to first
cigarette.2009;18(12). December 2009
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collectively help explain much of the remaining variation
in cotinine levels. Unmeasured genetic variability in ad-
diction and environmental factors that affect dependence
may also account for cotinine variability. In addition,
smoking intensity may be due to factors besides nicotine
dependence, including the tar yield and taste (27).
The regression slope for plasma cotinine did not differ
by sex, but significant differences by sex were found for
urinary cotinine. In pooled baseline data from four smok-
ing reduction trials, urinary cotinine levels peaked in men
(∼34 cigarettes daily) but continued to rise with cigarettes
per day in women (9). Sex differences in nicotine pharma-
cology have been reported but it is uncertain whether
these differences are due to physiologic, hormonal, or en-
vironmental factors (28-30). One possible explanation for
the effect of sex on urinary cotinine only is that there are
sex differences in the excretion of creatinine, which was
used as an adjustment factor for urinary volume. Age
was a significant independent predictor of plasma coti-
nine levels in our data, but the regression of cotinine
against cigarette frequency did not differ significantly
by age as was reported in the smoking reduction trials (9).
These observations underscore the methodologic issue
of the relative merits of blood, urine, and saliva as biolog-
ical sources for cotinine measurements. All three mea-
sures are consistent in determining smoking status.
When measuring exposure dose, the levels of biomarkers
will depend on assay sensitivity and specificity, exposure
conditions, and variation in metabolism and excretion.
Plasma and urinary cotinine are considered comparable
measurements of nicotine exposure based on similar rates
of elimination (31). However, creatinine production and
excretion is lower in the elderly, in women than in men,
in whites than in blacks, and in old age (32-34). TheCancer Epidemiol Biomarkers Prevextent to which creatinine adjustment affects the correla-
tion between urine and blood cotinine levels may vary
(35). In our data, the differences in correlation coefficients
between plasma cotinine and unadjusted or adjusted uri-
nary cotinine were minor.
Another methodologic issue is that nicotine is con-
verted into over one dozen metabolites. Cotinine accounts
for ∼10% of nicotine metabolites, but a complete metabol-
ic profile would provide greater accuracy for comparing
nicotine uptake between individuals. We are planning
such an analysis in the near future.
Nicotine dependence may be a factor in the success
of harm reduction programs, where success is measured
by decreased cigarette frequency and levels of smoking
and disease risk biomarkers (36, 37). In a meta-analyses
of 13 nicotine replacement trials, there was an overall
reduction in the average daily numbers of cigarettes
smoked but wide variability in the reduction of coti-
nine, carbon monoxide, and thiocyanate levels (38).
The reduced consumption of cigarettes might have been
offset by nicotine-dependent driven compensatory
smoking behaviors (39). Even if interventions success-
fully reduce cigarette consumption, concurrent reduc-
tions in biological exposure to tobacco smoke might
depend on nicotine dependence. In intervention pro-
grams, high dependence may require a proportionally
greater reduction in smoking frequency to receive simi-
lar health benefits as subjects who are less dependent. A
limited number of tobacco pharmacotherapy treatment
trials in black smokers measured time to first cigarette.
Participants who smoked >30 minutes after waking
were more successful quitters (40). In case-control data,
the excess odds ratio for lung cancer increases with
smoking frequency up to 20 cigarettes per day but
plateaus with higher cigarette frequency (14). ThisTable 3. Mean urinary cotinine values by time to first cigarette after waking in a community-based study,
New Yorkn Urinary cotinine
(μg/mg creatinine)P value for pairwise comparisons of mean
urinary cotinine levels95% CL2009;18(12). D6-30 minecember 200931-60 min >60 minTime to first cigarette (min)
<5 102 4,600 3,900-5,260 0.54 0.11 0.01
6-30 82 4,270 3,530-5,010 — 0.25 <0.05
31-60 41 3,530 2,450-4,610 — 0.28
>60 27 2,650 1,370-3,930NOTE: Mean values are adjusted for cigarettes per day, sex, and race.Table 2. Mean plasma cotinine values by time to first cigarette after waking in a community-based study,
New Yorkn Plasma cotinine (ng/mL) P value for pairwise comparison of mean plasma cotinine levels95% CL 6-30 min 31-60 min >60 minTime to first cigarette (min)
<5 96 437 380-494 0.05 <0.001 <0.001
6-30 79 352 291-413 — 0.02 0.03
31-60 40 229 140-317 — 0.85
>60 27 215 110-321NOTE: Mean values are adjusted for cigarettes per day, sex, and race.
Abbreviation: CL, confidence limits.
3419Cancer Epidemiology, Biomarkers & Preventionparallels the cigarette per day–cotinine relationship,
supporting the notion that biomarker levels reflect risk
and not just exposure.
A strength of the current study is that subjects were
not recruited as part of a smoking reduction trial where
a high motivation to quit could possibly bias the find-
ings. Limitations include possible misclassification of
nonsmokers as smokers, although none of the partici-
pants had blood cotinine levels <5 ng/mL, an optimal
cutpoint for distinguishing passive from active smoking
(41). We also assessed misclassification of reported
smoking amount in 133 subjects by comparison with
the number of cigarette butts saved and stored in a plas-
tic container the week before the study day (0.95 in
Blacks and 0.83 in Whites; ref. 1).
Differences in the time to first cigarette may represent a
constellation of factors that includes genetic variation in
nicotine dependence, variation in nongenetic behavioral
and social factors, and possibly variation in characteristics
of the cigarettes including taste. The fact that a simple
question is such a strong predictor of a biomarker of nic-
otine dependence seems quite noteworthy particularly be-
cause considerable efforts have been made to discover
relatively small effects of variants on nicotine dependence
in genome-wide scans. Because nicotine dependence (ci-
garettes per day, time after waking) is the major explana-
tory variable for the variation in cotinine levels, and
because cotinine levels seem to reflect the risk of lung can-
cer, time to first cigarette may be an important risk factor
for lung cancer and should be considered in the design of
smoking cessation programs.
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